XML 56 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Segments (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Jun. 30, 2018
Segment Reporting Information [Line Items]          
Net sales $ 218,223 $ 205,876 $ 418,376 $ 399,288  
Depreciation and amortization 6,841 6,631 13,532 13,275  
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 20,074 21,211 42,779 40,155  
Interest expense 3,015 3,050 5,798 6,168  
Depreciation and amortization 6,841 6,631 13,532 13,275  
Stock-based compensation     1,129    
Acquisition-related cost of goods sold       1,671  
Acquisition-related accrued compensation       924  
Foreign currency (gains) losses, net 2,617 (323) (18) 2  
Identifiable assets 697,292   697,292   $ 671,679
Animal Health          
Segment Reporting Information [Line Items]          
Net sales 139,562 132,845 270,751 261,686  
Mineral Nutrition          
Segment Reporting Information [Line Items]          
Net sales 62,319 59,616 117,157 111,689  
Performance Products          
Segment Reporting Information [Line Items]          
Net sales 16,342 13,415 30,468 25,913  
Operating Segments          
Segment Reporting Information [Line Items]          
Net sales 218,223 205,876 418,376 399,288  
Depreciation and amortization 6,388 6,108 12,614 12,193  
Adjusted EBITDA - Total segments 41,523 40,914 80,518 78,620  
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 20,074 21,211 42,779 40,155  
Interest expense 3,015 3,050 5,798 6,168  
Depreciation and amortization 6,388 6,108 12,614 12,193  
Stock-based compensation 564 0 1,129 0  
Acquisition-related cost of goods sold 0 1,422 0 1,671  
Acquisition-related accrued compensation 0 487 0 924  
Acquisition-related transaction costs 0 0 0 400  
Other, net (1,506) 0 (1,506) 0  
Foreign currency (gains) losses, net 2,617 (323) (18) 2  
Adjusted EBITDA - Total segments 41,523 40,914 80,518 78,620  
Identifiable assets 582,315   582,315   549,523
Operating Segments | Animal Health          
Segment Reporting Information [Line Items]          
Net sales 139,562 132,845 270,751 261,686  
Depreciation and amortization 5,493 5,265 10,849 10,519  
Adjusted EBITDA - Total segments 35,925 35,036 71,641 68,778  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 5,493 5,265 10,849 10,519  
Adjusted EBITDA - Total segments 35,925 35,036 71,641 68,778  
Identifiable assets 472,534   472,534   455,704
Operating Segments | Mineral Nutrition          
Segment Reporting Information [Line Items]          
Net sales 62,319 59,616 117,157 111,689  
Depreciation and amortization 616 584 1,213 1,169  
Adjusted EBITDA - Total segments 4,084 5,614 6,647 9,330  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 616 584 1,213 1,169  
Adjusted EBITDA - Total segments 4,084 5,614 6,647 9,330  
Identifiable assets 77,351   77,351   69,779
Operating Segments | Performance Products          
Segment Reporting Information [Line Items]          
Net sales 16,342 13,415 30,468 25,913  
Depreciation and amortization 279 259 552 505  
Adjusted EBITDA - Total segments 1,514 264 2,230 512  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 279 259 552 505  
Adjusted EBITDA - Total segments 1,514 264 2,230 512  
Identifiable assets 32,430   32,430   24,040
Corporate          
Segment Reporting Information [Line Items]          
Depreciation and amortization 453 523 918 1,082  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 453 523 918 1,082  
Corporate costs 9,918 $ 8,436 18,804 $ 16,025  
Identifiable assets $ 114,977   $ 114,977   $ 122,156